Pediatric and Off-Label Indications for Beconase
Beconase AQ is approved for use in children as young as six years old. Talk to your healthcare provider about the benefits and risks of using the drug in children.
On occasion, your healthcare provider may recommend Beconase AQ for something other than nasal allergies or polyps. Currently, off-label Beconase AQ uses include treatment of the following conditions:
- Nasal polyps (for treating them, rather than preventing them from returning after surgery)
- Sinus infections.